Antibiotic Modulation of Pseudomonas aeruginosa Virulence

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen implicated in life-threatening hospital-acquired infections, chronic lung colonisation in cystic fibrosis patients and a range of acute diseases. Its intrinsic resistance mechanisms, including efflux pumps and low-permeability outer membranes, are compounded by adaptive responses to environmental stressors. Central to its pathogenicity is a quorum sensing network that coordinates production of toxins, siderophores, motility factors and biofilm matrix components, collectively termed virulence factors. Conventional antibiotic regimens strive to achieve bactericidal activity, yet mounting resistance underscores the need for alternative interventions. Sub-inhibitory concentrations of certain antibiotics have emerged as modulators of virulence expression, attenuating pathogenic behaviour without imposing strong selective pressure for resistance. Macrolide antibiotics, for instance, can disrupt quorum sensing signal generation, repress the synthesis of pyoverdine, phenazines and exopolysaccharides, and sensitize bacteria to reactive oxygen species. High-throughput network analyses have identified novel genetic modules that underpin antibiotic-responsive pathogenicity, while animal infection models demonstrate that anti-virulence protocols enhance bacterial clearance and reduce tissue damage. By targeting regulatory circuits and cooperative behaviours, antibiotic modulation of virulence represents a promising strategy to complement conventional therapies, curb resistance development and improve patient outcomes globally.

Research from Nature Portfolio

Mechanistic insights into macrolide-mediated virulence attenuation have been illuminated by studies demonstrating that azithromycin, at concentrations below those required for growth inhibition, can substantially reduce homoserine lactone (HSL) signals. Quantitative analyses reveal that ribosomal interference by azithromycin selectively downregulates the las and rhl quorum sensing synthases, yielding a pronounced decline in HSL secretion. Further transcriptional profiling indicates that lasI functions as a population-density sensor while rhlI fine-tunes inter-system coordination, establishing a hierarchical model for quorum network modulation. This foundational work elucidates how sub-lethal antibiotic exposure can reprogram gene expression to impair virulence pathways without compromising bacterial viability, offering a blueprint for rational design of anti-virulence therapeutics.

Antibiotic Modulation of Pseudomonas aeruginosa Virulence publication trend

The graph below shows the total number of articles in antibiotic modulation of pseudomonas aeruginosa virulence across all publications each year (not limited to Nature Index journals).

Technical terms

Quorum sensing: Cell-density-dependent signalling mechanism by which bacteria coordinate collective behaviours, including virulence factor production.

Biofilm: Structured community of bacterial cells embedded in a self-produced extracellular matrix, conferring protection against antibiotics and host defences.

Virulence factor: Molecule or structure that enables a pathogen to colonise, damage host tissues or evade immune responses.

Minimum inhibitory concentration (MIC): Lowest antibiotic concentration that prevents visible bacterial growth in vitro.

Sub-inhibitory concentration (sub-MIC): Antibiotic level below the MIC, which can modulate bacterial gene expression without halting growth.

References

1. A gene network-driven approach to infer novel pathogenicity-associated genes: application to Pseudomonas aeruginosa PAO1. mSystems (2023).
2. Spiramycin Disarms Pseudomonas aeruginosa without Inhibiting Growth. Antibiotics (2023).
3. Mechanism of azithromycin inhibition of HSL synthesis in Pseudomonas aeruginosa. Scientific Reports (2016).
4. Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model. Frontiers in Microbiology (2021).
5. Sub-Inhibitory Antibiotic Exposure and Virulence in Pseudomonas aeruginosa. Antibiotics (2021).